The following vaccines (vaccine name/trade name, manufacturer, and information from the product insert) contain aluminum adjuvant:
DPT, Sanofi Pasteur Inc, "Each 0.5 mL dose is formulated to contain 6.7 Lf of diphtheria toxoid, 5 Lf of tetanus toxoid, and not more than 0.17 mg of aluminum."
DaPT/Tripedia, Sanofi Pasteur, Inc., "Each 0.5 mL dose also contains, by assay, not more than 0.170 mg of aluminum and not more than 100 μg (0.02%) of residual formaldehyde."
DaPT/Infanrix, GlaxoSmithKline Biologicals, "Each 0.5-mL dose contains 4.5 mg of NaCl and aluminum adjuvant (not more than 0.625 mg aluminum by assay). Each dose also contains ≤100 mcg of residual formaldehyde and ≤100 mcg of polysorbate 80 (Tween 80)."
DaPT/DAPTACEL, Sanofi Pasteur, Ltd., "Other ingredients per 0.5 mL dose include 1.5 mg aluminum phosphate (0.33 mg of aluminum) as the adjuvant, ≤5 μg residual formaldehyde, <50 ng residual glutaraldehyde and 3.3 mg (0.6% v/v) 2-phenoxyethanol (not as a preservative)."
DaPT, Hepatitis B (Recombinant) and Inactivated Poliovirus Vaccine Combined/Pediarix, GlaxoSmithKline Biologicals, "Each 0.5-mL dose also contains 4.5 mg of NaCl and aluminum adjuvant (not more than 0.85 mg aluminum by assay). Each dose also contains ≤100 mcg of residual formaldehyde and ≤100 mcg of polysorbate 80 (Tween 80)."
DaPT and Inactivated Poliovirus Vaccine/Kinrix, GlaxoSmithKline Biologicals, "Each 0.5-mL dose contains 4.5 mg of NaCl and aluminum adjuvant (not more than 210 0.6 mg aluminum by assay). Each dose also contains ≤100 mcg of residual formaldehyde and 211 ≤100 mcg of polysorbate 80 (Tween 80)."
DaPT, Inactivated Poliovirus and HIB Conjugate Vaccine/Pentacel, Sanofi Pasteur, Ltd, "Other ingredients per 0.5 mL dose include 1.5 mg aluminum phosphate (0.33 mg aluminum) as the adjuvant, polysorbate 80 (approximately 10 ppm by calculation), ≤5 μg residual formaldehyde, <50 ng residual glutaraldehyde, ≤50 ng residual bovine serum albumin, 3.3 mg (0.6% v/v) 2-phenoxyethanol (not as a preservative) and <4 pg of neomycin and <4 pg polymyxin B sulfate. "
Hepatitis A Vaccine, Inactivated/Havrix, GlaxoSmithKline Biologicals, "Each 1-mL adult dose of vaccine consists of 1440 EL.U. of viral antigen, adsorbed on 0.5 mg of aluminum as aluminum hydroxide. Each 0.5-mL pediatric dose of vaccine consists of 720 EL.U. of viral antigen, adsorbed onto 0.25 mg of aluminum as aluminum hydroxide."
Hepatitis A Vaccine, Inactivated/VAQTA, Merck & Co, Inc, "Pediatric/Adolescent Formulation (12 Months Through 18 Years of Age): each 0.5 mL dose contains approximately 25U of hepatitis A virus antigen adsorbed onto approximately 0.225 mg of aluminum provided as amorphous aluminum hydroxyphosphate sulfate, and 35 mcg of sodium borate as a pH stabilizer, in 0.9% sodium chloride. Adult Formulation (19 Years of Age and Older): each 1 mL dose contains approximately 50U of hepatitis A virus antigen adsorbed onto approximately 0.45 mg of aluminum provided as amorphous aluminum hydroxyphosphate sulfate, and 70 mcg of sodium borate as a pH stabilizer, in 0.9% sodium chloride."
Hepatitis A Inactivated & Hepatitis B (Recombinant) Vaccine/Twinrix, GlaxoSmithKline Biologicals, "A 1.0-mL dose of vaccine contains 720 ELISA Units of inactivated hepatitis A virus and 20 mcg of recombinant HBsAg protein. One dose of vaccine also contains 0.45 mg of aluminum in the form of aluminum phosphate and aluminum hydroxide as adjuvants, amino acids, 5.0 mg 2-phenoxyethanol as a preservative, sodium chloride, phosphate buffer, polysorbate 20, Water for Injection, traces of formalin (not more than 0.1 mg), a trace amount of thimerosal (<1 mcg mercury) from the manufacturing process, and residual MRC-5 cellular proteins (not more than 2.5 mcg)."
Hepatitis B Vaccine (Recombinant)/Engerix-B, GlaxoSmithKline Biologicals, "Pediatric/Adolescent: Each 0.5-mL dose contains 10 mcg of hepatitis B surface antigen adsorbed on 0.25 mg aluminum as aluminum hydroxide. The pediatric formulation contains sodium chloride (9 mg/mL) and phosphate buffers (disodium phosphate dihydrate, 0.98 mg/mL; sodium dihydrogen phosphate dihydrate, 0.71 mg/mL). Adult: Each 1-mL adult dose contains 20 mcg of hepatitis B surface antigen adsorbed on 0.5 mg aluminum as aluminum hydroxide. The adult formulation contains sodium chloride (9 mg/mL) and phosphate buffers (disodium phosphate dihydrate, 0.98 mg/mL; sodium dihydrogen phosphate dihydrate, 0.71 mg/mL)."
Hepatitis B Vaccine (Recombinant)/Recombivax HB, Merck & Co, Inc, "All formulations contain approximately 0.5 mg of aluminum (provided as amorphous aluminum hydroxyphosphate sulfate, previously referred to as aluminum hydroxide) per mL of vaccine. In each formulation, hepatitis B surface antigen is adsorbed onto approximately 0.5 mg of aluminum (provided as amorphous aluminum hydroxyphosphate sulfate) per mL of vaccine."
Human Papillomavirus Quadrivalent (Types 6, 11, 16, 18) Vaccine, Recombinant/Gardasil, Merck & Co, Inc, "Each 0.5-mL dose of the vaccine contains approximately 225 mcg of aluminum (as Amorphous Aluminum Hydroxyphosphate Sulfate adjuvant), 9.56 mg of sodium chloride, 0.78 mg of L-histidine, 50 mcg of polysorbate 80, 35 mcg of sodium borate, < 7 mcg yeast protein/dose, and water for injection. The product does not contain a preservative or antibiotics."
Pneumococcal 7-valent Conjugate Vaccine (Diphtheria CRM197 Protein)/Prevnar, Wyeth Pharmaceuticals, Inc, "Each 0.5 mL dose is formulated to contain: 2 μg of each saccharide for serotypes 4, 9V, 14, 18C, 19F, and 23F, and 4 μg of serotype 6B per dose (16 μg total saccharide); approximately 20 μg of CRM197 carrier protein; and 0.125 mg of aluminum per 0.5 mL dose as aluminum phosphate adjuvant."